These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 8083675
21. Absence of placebo response in obsessive-compulsive disorder. Mavissakalian MR, Jones B, Olson S. J Nerv Ment Dis; 1990 Apr; 178(4):268-70. PubMed ID: 2319236 [Abstract] [Full Text] [Related]
22. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine. Hoehn-Saric R, McLeod DR, Zimmerli WD, Hipsley PA. J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655 [Abstract] [Full Text] [Related]
23. Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study. Montgomery SA, Montgomery DB, Fineberg N. Prog Neuropsychopharmacol Biol Psychiatry; 1990 Jul; 14(5):719-27. PubMed ID: 2293252 [Abstract] [Full Text] [Related]
24. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder. DeVeaugh-Geiss J, Landau P, Katz R. Psychopharmacol Bull; 1989 Jul; 25(1):36-40. PubMed ID: 2672070 [Abstract] [Full Text] [Related]
25. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder. Rasmussen SA. Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460 [Abstract] [Full Text] [Related]
26. Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results. Pigott TA, Pato MT, Bernstein SE, Grover GN, Hill JL, Tolliver TJ, Murphy DL. Arch Gen Psychiatry; 1990 Oct; 47(10):926-32. PubMed ID: 2222131 [Abstract] [Full Text] [Related]
27. Clomipramine in obsessive compulsive disorder. Lee S. J Clin Psychiatry; 1991 Apr; 52(4):183-5. PubMed ID: 2016256 [No Abstract] [Full Text] [Related]
28. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder. Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL. Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696 [Abstract] [Full Text] [Related]
29. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P. J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246 [Abstract] [Full Text] [Related]
30. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial. Vallejo J, Olivares J, Marcos T, Bulbena A, Menchón JM. Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616 [Abstract] [Full Text] [Related]
32. Double-blind controlled study in phobias and obsessions. Karabanow O. J Int Med Res; 1977 Nov; 5 Suppl 5():42-8. PubMed ID: 340306 [Abstract] [Full Text] [Related]
34. A controlled study of trazodone, imipramine, and placebo in outpatients with endogenous depression. Mann JJ, Georgotas A, Newton R, Gershon S. J Clin Psychopharmacol; 1981 Mar; 1(2):75-80. PubMed ID: 7028798 [Abstract] [Full Text] [Related]
35. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ. J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291 [Abstract] [Full Text] [Related]
40. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder. Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL. Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]